Literature DB >> 16732566

Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early disease.

Lucy Gardner1, Catherine Wilson, Angela M Patterson, Barry Bresnihan, Oliver FitzGerald, Michael A Stone, Brian A Ashton, Jim Middleton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732566     DOI： 10.1002/art.21909

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

3.  The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.

Authors:  Monika Pruenster; Liesbeth Mudde; Paula Bombosi; Svetla Dimitrova; Marion Zsak; Jim Middleton; Ann Richmond; Gerard J Graham; Stephan Segerer; Robert J B Nibbs; Antal Rot
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

Review 4.  DARC and D6: silent partners in chemokine regulation?

Authors:  Chris A H Hansell; Catherine E Hurson; Robert J B Nibbs
Journal:  Immunol Cell Biol       Date:  2010-12-14       Impact factor: 5.126

Review 5.  Atypical chemokine receptors.

Authors:  Maria Helena Ulvmar; Elin Hub; Antal Rot
Journal:  Exp Cell Res       Date:  2011-01-25       Impact factor: 3.905

Review 6.  Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

Authors:  Jean-Luc Galzi; Muriel Hachet-Haas; Dominique Bonnet; Francois Daubeuf; Sandra Lecat; Marcel Hibert; Jacques Haiech; Nelly Frossard
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

7.  CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.

Authors:  Julie Catusse; David J Clark; Ursula A Gompels
Journal:  J Inflamm (Lond)       Date:  2009-07-30       Impact factor: 4.981

8.  Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.

Authors:  Emily Smith; Helen M McGettrick; Michael A Stone; John S Shaw; Jim Middleton; Gerard B Nash; Christopher D Buckley; G Ed Rainger
Journal:  Arthritis Rheum       Date:  2008-07

9.  Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.

Authors:  Igor Novitzky-Basso; Antal Rot
Journal:  Front Immunol       Date:  2012-08-17       Impact factor: 7.561

10.  Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice.

Authors:  Oksana Kehoe; Neena Kalia; Sophie King; Andrew Eustace; Charlotte Boyes; Ofer Reizes; Anwen Williams; Angela Patterson; Jim Middleton
Journal:  Arthritis Res Ther       Date:  2014-07-11       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.